Cargando…

Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases

BACKGROUND: Primary intrathoracic liposarcoma is an extremely rare malignancy as well as a rare histologic subtype of intrathoracic sarcoma. Relatively few reports appear in the world literatures. We explored the clinicopathologic features and prognostic factors of this tumor in this study. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ming, Yang, Jun, Zhu, Lei, Zhou, Cao, Zhao, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088306/
https://www.ncbi.nlm.nih.gov/pubmed/24993036
http://dx.doi.org/10.1186/1749-8090-9-119
_version_ 1782324926836899840
author Chen, Ming
Yang, Jun
Zhu, Lei
Zhou, Cao
Zhao, Heng
author_facet Chen, Ming
Yang, Jun
Zhu, Lei
Zhou, Cao
Zhao, Heng
author_sort Chen, Ming
collection PubMed
description BACKGROUND: Primary intrathoracic liposarcoma is an extremely rare malignancy as well as a rare histologic subtype of intrathoracic sarcoma. Relatively few reports appear in the world literatures. We explored the clinicopathologic features and prognostic factors of this tumor in this study. METHODS: We retrospectively analyzed the clinicopathological data of 23 patients with primary intrathoracic liposarcoma who were treated in Shanghai chest Hospital affiliated to Jiao Tong University, from January 2003 to March 2013. These patients were classified into three groups according to the distinct tumor locations, including mediastinum, pleura and lung liposarcoma. Also, these patients could be divided into four types, including well-differentiated, myxoid, dedifferentiated and pleomorphic liposarcoma. The influences of age, sex, tumor size, tumor location, tumor histologic type and therapy on the prognosis of the patients were analyzed. RESULTS: There were no significant difference for survival among distinct liposarcoma locations. However, significant difference for survival among distinct liposarcoma types were observed. Poor disease-free survival (DFS) was observed in the myxoid, pleomorphic and dedifferentiated types as compared to well-differentiated type (P = 0.038). Inferior overall-survival (OS) was observed in dedifferentiated, pleomorphic and myxoid types relative to well-differentiated type (P = 0.027). The radical surgery was a favorable prognostic factor for OS, as demonstrated by the better OS of the radical surgery group as compared to that of the non-radical surgery group ( P = 0.029). Notably, there were no significant differences for DFS and OS in other clinical parameters including tumor size, gender and age. In addition, radiotherapy and/or chemotherapy could not improve the prognosis of the patients receiving non-radical surgery or suffering from relapse. CONCLUSIONS: The histological type and the radical surgery are the factors that influence the behavior and prognosis of liposarcoma. In general, radiotherapy and chemotherapy are believed to be ineffective therapeutic modalities for survival. So it is essential to completely resect the primary intrathoracic liposarcoma as radical cure of the disease.
format Online
Article
Text
id pubmed-4088306
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40883062014-07-10 Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases Chen, Ming Yang, Jun Zhu, Lei Zhou, Cao Zhao, Heng J Cardiothorac Surg Research Article BACKGROUND: Primary intrathoracic liposarcoma is an extremely rare malignancy as well as a rare histologic subtype of intrathoracic sarcoma. Relatively few reports appear in the world literatures. We explored the clinicopathologic features and prognostic factors of this tumor in this study. METHODS: We retrospectively analyzed the clinicopathological data of 23 patients with primary intrathoracic liposarcoma who were treated in Shanghai chest Hospital affiliated to Jiao Tong University, from January 2003 to March 2013. These patients were classified into three groups according to the distinct tumor locations, including mediastinum, pleura and lung liposarcoma. Also, these patients could be divided into four types, including well-differentiated, myxoid, dedifferentiated and pleomorphic liposarcoma. The influences of age, sex, tumor size, tumor location, tumor histologic type and therapy on the prognosis of the patients were analyzed. RESULTS: There were no significant difference for survival among distinct liposarcoma locations. However, significant difference for survival among distinct liposarcoma types were observed. Poor disease-free survival (DFS) was observed in the myxoid, pleomorphic and dedifferentiated types as compared to well-differentiated type (P = 0.038). Inferior overall-survival (OS) was observed in dedifferentiated, pleomorphic and myxoid types relative to well-differentiated type (P = 0.027). The radical surgery was a favorable prognostic factor for OS, as demonstrated by the better OS of the radical surgery group as compared to that of the non-radical surgery group ( P = 0.029). Notably, there were no significant differences for DFS and OS in other clinical parameters including tumor size, gender and age. In addition, radiotherapy and/or chemotherapy could not improve the prognosis of the patients receiving non-radical surgery or suffering from relapse. CONCLUSIONS: The histological type and the radical surgery are the factors that influence the behavior and prognosis of liposarcoma. In general, radiotherapy and chemotherapy are believed to be ineffective therapeutic modalities for survival. So it is essential to completely resect the primary intrathoracic liposarcoma as radical cure of the disease. BioMed Central 2014-07-04 /pmc/articles/PMC4088306/ /pubmed/24993036 http://dx.doi.org/10.1186/1749-8090-9-119 Text en Copyright © 2014 Chen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chen, Ming
Yang, Jun
Zhu, Lei
Zhou, Cao
Zhao, Heng
Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases
title Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases
title_full Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases
title_fullStr Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases
title_full_unstemmed Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases
title_short Primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases
title_sort primary intrathoracic liposarcoma: a clinicopathologic study and prognostic analysis of 23 cases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088306/
https://www.ncbi.nlm.nih.gov/pubmed/24993036
http://dx.doi.org/10.1186/1749-8090-9-119
work_keys_str_mv AT chenming primaryintrathoracicliposarcomaaclinicopathologicstudyandprognosticanalysisof23cases
AT yangjun primaryintrathoracicliposarcomaaclinicopathologicstudyandprognosticanalysisof23cases
AT zhulei primaryintrathoracicliposarcomaaclinicopathologicstudyandprognosticanalysisof23cases
AT zhoucao primaryintrathoracicliposarcomaaclinicopathologicstudyandprognosticanalysisof23cases
AT zhaoheng primaryintrathoracicliposarcomaaclinicopathologicstudyandprognosticanalysisof23cases